![](https://investorshub.advfn.com/uicon/577752.png?cb=1480694928)
Friday, December 02, 2016 2:42:29 PM
Remember the PR on Nov 15th: "OWCP announced it is submitting the final Psoriasis IRB safety protocol for the Israeli national IRB committee at the Health Minister office and the national IRB committee is scheduled to ensemble at the beginning of December 2016"
So I did some research online and found out that IRB committee meets on Sundays and Mondays.
http://www.tasmc.org.il/sites/en/Research/Clinical-Trials/Pages/Helsinki.aspx
Since the PR mentioned "beginning of December", I suppose the meeting is this Sunday and Monday, the 4th and 5th. So IMO, a big PR is coming Monday or Tuesday the latest with IRB approval for safety tests.
Efficacy tests are already ongoing and we know that the results are great. Once the safety tests are completed by March, the cream will be ready hit the markets.
So buckle up longs, starting from early next week volume should come IMO and $OWCP will make us all rich in Q1 2017!
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM